Articles with "intraperitoneal chemotherapy" as a keyword



Photo from wikipedia

Intraperitoneal chemotherapy: Hot, timely, and relevant?

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer"

DOI: 10.1002/cncr.33163

Abstract: Only 45% of women diagnosed with epithelial ovarian cancer (EOC) will remain alive 5 years after their diagnosis. For several decades, we have seen little progress in terms of overall survival (OS). However, we have… read more here.

Keywords: chemotherapy; use; chemotherapy hot; delivery ... See more keywords
Photo from wikipedia

Postoperative complications affect long‐term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.24632

Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.

Keywords: hyperthermic intraperitoneal; surgery hyperthermic; colorectal peritoneal; intraperitoneal chemotherapy ... See more keywords
Photo from wikipedia

Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.25603

Abstract: Background and objectives: Hypertherm intraperitoneal chemotherapy (HIPEC) is increasingly used in the treatment of ovarian, tubal, and primary peritoneal cancer (OC). The aim was to evaluate short‐term morbidity of cytoreductive surgery (CRS) and carboplatin HIPEC. read more here.

Keywords: peritoneal cancer; intraperitoneal chemotherapy; primary peritoneal; morbidity cytoreductive ... See more keywords
Photo from wikipedia

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.25939

Abstract: Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved… read more here.

Keywords: hyperthermic intraperitoneal; learning curve; intraperitoneal chemotherapy; curve ... See more keywords
Photo from wikipedia

Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.26099

Abstract: Variations in care have been demonstrated both within and among institutions in many clinical settings. By standardizing perioperative practices, Enhanced Recovery After Surgery (ERAS) pathways reduce variation in perioperative care. We sought to characterize the… read more here.

Keywords: recovery; enhanced recovery; surgery; variation ... See more keywords
Photo by jonathanborba from unsplash

Feasibility and effectiveness of opioid-free anesthesia in cytoreductive surgery with or without heated intraperitoneal chemotherapy.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of surgical oncology"

DOI: 10.1002/jso.26833

Abstract: BACKGROUND Opioid-free anesthesia (OFA) provides analgesia minimizing opioids. OFA has not been evaluated in cytoreductive surgery (CRS) with or without heated intraperitoneal chemotherapy. We aim to evaluate OFA feasibility and effectiveness in CRS. METHODS Retrospective… read more here.

Keywords: opioid free; intraperitoneal chemotherapy; cytoreductive surgery; free anesthesia ... See more keywords
Photo from wikipedia

Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgery

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.26969

Abstract: Failure to rescue (FTR) is defined as death after a major complication. We evaluated FTR after cytoreductive surgery (CRS) with and without hyperthermic intraperitoneal chemotherapy (HIPEC). read more here.

Keywords: intraperitoneal chemotherapy; major complication; hyperthermic intraperitoneal; failure rescue ... See more keywords
Photo from wikipedia

Impact of myometrium invasion on survival outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC)

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27122

Abstract: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is an effective surgical intervention for peritoneal surface malignancy. The effect of myometrium invasion on outcomes is unknown. read more here.

Keywords: chemotherapy crs; surgery hyperthermic; intraperitoneal chemotherapy; hyperthermic intraperitoneal ... See more keywords
Photo from wikipedia

Hyperthermic intraperitoneal chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom?

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27125

Abstract: The aim of this study is to evaluate the progression‐free survival (PFS) of recurrent ovarian cancer (ROC) patients treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC). read more here.

Keywords: intraperitoneal chemotherapy; ovarian cancer; hyperthermic intraperitoneal; recurrent ovarian ... See more keywords
Photo by jonathanborba from unsplash

Quality and readability assessment of online patient information on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27143

Abstract: We aim to assess the quality and readability of online information available to patients considering cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC). read more here.

Keywords: quality readability; surgery hyperthermic; intraperitoneal chemotherapy; hyperthermic intraperitoneal ... See more keywords
Photo by nci from unsplash

Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi‐institutional retrospective analysis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Surgical Oncology"

DOI: 10.1002/jso.27171

Abstract: There is a paucity of evidence on the value of intraperitoneal chemotherapy (IPC) following cytoreductive surgery (CRS) for colorectal peritoneal metastasis. This study aimed to evaluate the association between mitomycin C‐IPC and survival outcomes following… read more here.

Keywords: colorectal peritoneal; cytoreductive surgery; intraperitoneal chemotherapy; peritoneal metastasis ... See more keywords